- Home
- >
-
![When Surgery Alone Isn’t Enough: ALA-PDT Delivers a 23-Month Recurrence-Free Breakthrough for Periocular BCC]()
When Surgery Alone Isn’t Enough: ALA-PDT Delivers a 23-Month Recurrence-Free Breakthrough for Periocular BCC
This article presents three cases of periocular basal cell carcinoma (pBCC) treated with palliative surgery followed by ALA-PDT, achieving clinical cure with no recurrence over 12-23 months and excellent cosmetic outcomes. This combined approach offers a feasible option when complete surgical resection is challenging. -
![Case Report-ALA-PDT Combined with Surgery Successfully Treats Basal Cell Carcinoma(BCC)Within a Sebaceous Nevus:A 6-Month Follow-Up with No Recurrence]()
Case Report-ALA-PDT Combined with Surgery Successfully Treats Basal Cell Carcinoma(BCC)Within a Sebaceous Nevus:A 6-Month Follow-Up with No Recurrence
A clinical case report confirms the successful treatment of basal cell carcinoma (BCC) within a sebaceous nevus using ALA-PDT combined with surgical excision. The patient experienced full recovery with no recurrence after six months. Learn more about this innovative dermatological approach.
Get the latest price? We'll respond as soon as possible(within 12 hours)